IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Disc Medicine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$78.93+22.09 (+38.86%)
Close on Oct 19, 2026
- Market cap
- $3.05B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$11.01 (−12.24%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $3.05B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 4.74
- Dividend yield
- –
- Free cash flow yield
- -6.47%
Fundamentals
- Net income
- -$245.89M
- EPS, diluted
- -$6.57
- Free cash flow
- -$197.58M
- Book value per share
- $16.65
- Diluted shares
- 39M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Operating income
-$269.27M
Net income
-$245.89M
EPS, diluted
-$6.57
Free cash flow
-$197.58M
Reported periodTrailing twelve months